You are not wrong about the pre-clinical results being too compelling to ignore!
Taken from the investor presentation (https://hotcopper.com.au/threads/ann-gold-coast-investment-showcase-presentation.6123575/)
(1) The results from the rat model were bananas
(2) This was followed up by a pig model, that more closely reflects human pathology (taken from https://hotcopper.com.au/threads/ann-positive-results-in-glaucoma-pig-model.5276629/)
It looks that EmtinB when injected into a pig (the animal with the pathology most similar to that of a human), showed statistical significance to reduce Glaucoma - at least in those cases that mimic the worst human pathology...
(3) The peptide was modelled off something naturally occurring in our immune systems anyway, is safe, and hits the target
GLTAH
- Forums
- ASX - By Stock
- NSB
- Potential 100 bagger Biotech missed by the market
Potential 100 bagger Biotech missed by the market, page-988
-
- There are more pages in this discussion • 531 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.639M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 465000 | 3.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 274977 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 465000 | 0.036 |
3 | 210000 | 0.035 |
1 | 100000 | 0.034 |
5 | 290133 | 0.033 |
1 | 200000 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 274977 | 3 |
0.042 | 178333 | 3 |
0.043 | 240000 | 2 |
0.044 | 324875 | 2 |
0.045 | 20000 | 1 |
Last trade - 16.12pm 10/10/2024 (20 minute delay) ? |
Featured News
NSB (ASX) Chart |
Day chart unavailable
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online